- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2318
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Healthcare cost expenditures associated to frailty and sarcopenia ; volume:22 ; number:1 ; day:13 ; month:9 ; year:2022 ; pages:1-12 ; date:12.2022
BMC geriatrics ; 22, Heft 1 (13.9.2022), 1-12, 12.2022
- Creator
-
Álvarez-Bustos, Alejandro
Rodríguez-Sánchez, Beatriz
Carnicero-Carreño, Jose A.
Sepúlveda-Loyola, Walter
Garcia-Garcia, Francisco J.
Rodríguez-Mañas, Leocadio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12877-022-03439-z
- URN
-
urn:nbn:de:101:1-2022113021015584523828
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Álvarez-Bustos, Alejandro
- Rodríguez-Sánchez, Beatriz
- Carnicero-Carreño, Jose A.
- Sepúlveda-Loyola, Walter
- Garcia-Garcia, Francisco J.
- Rodríguez-Mañas, Leocadio
- SpringerLink (Online service)
Other Objects (12)
Sarcopenia and the syndrome of frailty
Lifetime healthcare expenditures across socioeconomic groups
Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty
Do Malnutrition, Sarcopenia and Frailty Overlap in Nursing-Home Residents?
Healthcare expenditures vs. health of the population
Does drug price-regulation affect healthcare expenditures?
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Frailty-aware care: giving value to frailty assessment across different healthcare settings
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis
Inequality of opportunity in healthcare expenditures: evidence from China
Sarcopenia and the syndrome of frailty
Lifetime healthcare expenditures across socioeconomic groups
Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty
Do Malnutrition, Sarcopenia and Frailty Overlap in Nursing-Home Residents?
Healthcare expenditures vs. health of the population
Does drug price-regulation affect healthcare expenditures?
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Frailty-aware care: giving value to frailty assessment across different healthcare settings
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis
Inequality of opportunity in healthcare expenditures: evidence from China
Sarcopenia and the syndrome of frailty
Lifetime healthcare expenditures across socioeconomic groups
Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty
Do Malnutrition, Sarcopenia and Frailty Overlap in Nursing-Home Residents?
Healthcare expenditures vs. health of the population
Does drug price-regulation affect healthcare expenditures?
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Frailty-aware care: giving value to frailty assessment across different healthcare settings
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis